SIGA Technologies, Inc. (SIGA)
Market: NASD |
Currency: USD
Address: 31 East 62nd Street
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
📈 SIGA Technologies, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.600000 |
- |
2025-04-29 |
- |
Dividend payout |
|
Total Amount for 2025: $0.600000 |
| 2024 |
- |
$0.600000 |
- |
2024-03-25 |
- |
Dividend payout |
|
Total Amount for 2024: $0.600000 |
| 2023 |
- |
$0.450000 |
- |
2023-05-15 |
- |
Dividend payout |
|
Total Amount for 2023: $0.450000 |
| 2022 |
- |
$0.450000 |
- |
2022-05-16 |
- |
Dividend payout |
|
Total Amount for 2022: $0.450000 |
📅 Earnings & EPS History for SIGA Technologies, Inc.
| Date | Reported EPS |
|---|
| 2026-05-06 (estimated upcoming) | - |
| 2026-03-09 (estimated upcoming) | - |
| 2025-11-05 (estimated upcoming) | - |
| 2025-07-30 (estimated upcoming) | - |
| 2025-05-08 | - |
| 2025-03-11 | - |
| 2024-11-07 | - |
| 2024-08-01 | - |
| 2024-05-07 | - |
| 2024-03-12 | - |
| 2023-11-07 | - |
| 2023-08-08 | - |
| 2023-05-04 | - |
| 2023-03-02 | - |
| 2022-11-03 | - |
| 2022-08-04 | - |
| 2022-05-05 | - |
| 2022-03-03 | - |
| 2021-11-04 | - |
| 2021-08-05 | - |
| 2021-05-06 | - |
| 2021-03-04 | - |
| 2020-11-05 | - |
| 2020-08-06 | - |
| 2020-05-06 | - |
| 2020-03-05 | - |
📰 Related News & Research
No related articles found for "siga technologies".
